1 - 25 of
51
results
for author:"King B."
in Literature Citations
| Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors. Wildman S.S., Boone M., Peppiatt-Wildman C.M., Contreras-Sanz A., King B.F., Shirley D.G., Deen P.M., Unwin R.J. J. Am. Soc. Nephrol. 20:1480-1490(2009) · Mapped (10) |
| JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal. Santaguida M., Schepers K., King B., Sabnis A.J., Forsberg E.C., Attema J.L., Braun B.S., Passegue E. Cancer Cell 15:341-352(2009) · Mapped (7) |
| Root-selective expression of AtCAX4 and AtCAX2 results in reduced lamina cadmium in field-grown Nicotiana tabacum L. Korenkov V., King B., Hirschi K., Wagner G.J. Plant Biotechnol. J. 7:219-226(2009) · Mapped (2) |
| Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase. Kirkland T.A., Adler M., Bauman J.G., Chen M., Haeggstrom J.Z., King B., Kochanny M.J., Liang A.M., Mendoza L., Phillips G.B. et al. Bioorg. Med. Chem. 16:4963-4983(2008) · Mapped (1) |
| Role of the Caenorhabditis elegans multidrug resistance gene, mrp-4, in gut granule differentiation. Currie E., King B., Lawrenson A.L., Schroeder L.K., Kershner A.M., Hermann G.J. Genetics 177:1569-1582(2007) · Mapped (8) |
| Genetic analysis of albuminuria in a cross between C57BL/6J and DBA/2J mice. Sheehan S., Tsaih S.W., King B.L., Stanton C., Churchill G.A., Paigen B., DiPetrillo K. Am. J. Physiol. Renal Physiol. 293:F1649-56(2007) · Mapped (20) |
| A double-bromodomain protein, FSH-S, activates the homeotic gene ultrabithorax through a critical promoter-proximal region. Chang Y.L., King B., Lin S.C., Kennison J.A., Huang D.H. Mol. Cell. Biol. 27:5486-5498(2007) · Mapped (19) |
| P2X receptor signaling inhibits BDNF-mediated spiral ganglion neuron development in the neonatal rat cochlea. Greenwood D., Jagger D.J., Huang L.C., Hoya N., Thorne P.R., Wildman S.S., King B.F., Pak K., Ryan A.F., Housley G.D. Development 134:1407-1417(2007) · Mapped (1) |
| A polymorphism in New Zealand inbred mouse strains that inactivates phosphatidylcholine transfer protein. Pan H.J., Agate D.S., King B.L., Wu M.K., Roderick S.L., Leiter E.H., Cohen D.E. FEBS Lett. 580:5953-5958(2006) · Mapped (2) |
| AQUA and FISH analysis of HER-2/neu expression and amplification in a small cell lung carcinoma tissue microarray. Giltnane J.M., Murren J.R., Rimm D.L., King B.L. Histopathology 49:161-169(2006) · Mapped (8) |
| Contribution of CYP2C9 to variability in vitamin K antagonist metabolism. Daly A.K., King B.P. Expert Opin Drug Metab Toxicol 2:3-15(2006) · Mapped (8) |
| Altered growth characteristics of skin fibroblasts from wild-derived mice, and genetic loci regulating fibroblast clone size. Yuan R., Flurkey K., Van Aelst-Bouma R., Zhang W., King B., Austad S., Miller R.A., Harrison D.E. Aging Cell 5:203-212(2006) · Mapped (4) |
| Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Crawley A.C., Gliddon B.L., Auclair D., Brodie S.L., Hirte C., King B.M., Fuller M., Hemsley K.M., Hopwood J.J. Brain Res. 1104:1-17(2006) · Mapped (6) |
| A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Bejerano G., Lowe C.B., Ahituv N., King B., Siepel A., Salama S.R., Rubin E.M., Kent W.J., Haussler D. Nature 441:87-90(2006) · Mapped (4) |
| Fas-ligand is stored in secretory lysosomes of ocular barrier epithelia and released with microvesicles. McKechnie N.M., King B.C., Fletcher E., Braun G. Exp. Eye Res. 83:304-314(2006) · Mapped (1) |
| Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate. Murphy N., Diviney M., Szer J., Bardy P., Grigg A., Hoyt R., King B., Macgregor L., Holdsworth R., McCluskey J. et al. Bone Marrow Transplant. 37:773-779(2006) · Mapped (9) |
| Identification of a family of DNA-binding proteins with homology to RNA splicing factors. Shipman K.L., Robinson P.J., King B.R., Smith R., Nicholson R.C. Biochem. Cell Biol. 84:9-19(2006) · UniProtKB (1) · Mapped (1) |
| Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA. King B., Savas P., Fuller M., Hopwood J., Hemsley K. Mol. Genet. Metab. 87:107-112(2006) · Mapped (6) |
| The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Sconce E.A., Khan T.I., Wynne H.A., Avery P., Monkhouse L., King B.P., Wood P., Kesteven P., Daly A.K., Kamali F. Blood 106:2329-2333(2005) · Mapped (11) |
| A mathematical and computational framework for quantitative comparison and integration of large-scale gene expression data. Hart C.E., Sharenbroich L., Bornstein B.J., Trout D., King B., Mjolsness E., Wold B.J. Nucleic Acids Res. 33:2580-2594(2005) · Mapped (7) |
| Upstream and coding region CYP2C9 polymorphisms: correlation with warfarin dose and metabolism. King B.P., Khan T.I., Aithal G.P., Kamali F., Daly A.K. Pharmacogenetics 14:813-822(2004) · Mapped (8) |
| Identification of the Arabidopsis palmitoyl-monogalactosyldiacylglycerol Delta7-desaturase gene FAD5, and effects of plastidial retargeting of Arabidopsis desaturases on the fad5 mutant phenotype. Heilmann I., Mekhedov S., King B., Browse J., Shanklin J. Plant Physiol. 136:4237-4245(2004) · UniProtKB (2) · Mapped (2) |
| Phenotype-genotype correlations in a series of wolfram syndrome families. Smith C.J., Crock P.A., King B.R., Meldrum C.J., Scott R.J. Diabetes Care 27:2003-2009(2004) · Mapped (2) |
| Mutations in SEC63 cause autosomal dominant polycystic liver disease. Davila S., Furu L., Gharavi A.G., Tian X., Onoe T., Qian Q., Li A., Cai Y., Kamath P.S., King B.F. et al. |
| Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin. Kamali F., Khan T.I., King B.P., Frearson R., Kesteven P., Wood P., Daly A.K., Wynne H. Clin. Pharmacol. Ther. 75:204-212(2004) · Mapped (8) |
